Latest news with #HalfYearReport
Yahoo
6 days ago
- Business
- Yahoo
Half-Year Report on Liquidity Contract with Invest Securities
Half-Year Report on Liquidity Contract with Invest Securities NANTES, France - July 16, 2025, 6:00pm CET – Under the liquidity contract entrusted by OSE Immunotherapeutics to Invest Securities, the following assets were recorded on the liquidity account as of June 30, 2025: 27,792 shares 454,733.83 euros in cash As a reminder, at December 31, 2024, the following assets were recorded on the liquidity account: 42,457 shares 332,969.24 euros in cash As a reminder, at the time of the implementation of the liquidity contract on April 25, 2015, the following assets were recorded in the liquidity accounts: 0 shares 300,000 euros in cash ABOUT OSE IMMUNOTHERAPEUTICSOSE Immunotherapeutics is a biotech company dedicated to developing first-in-class assets in immuno-oncology (IO) and immuno-inflammation (I&I) that address the unmet patient needs of today and tomorrow. We partner with leading academic institutions and biopharmaceutical companies in our efforts to develop and bring to the market transformative medicines for people with serious diseases. OSE Immunotherapeutics is based between Nantes and Paris and is quoted on Euronext. Additional information about OSE Immunotherapeutics assets is available on the Company's website: Follow us on LinkedIn. Contacts Fiona Dé France Contact Media: FP2COMFlorence Portejoiefportejoie@ 6 07 768 283 Forward-looking statements This press release contains express or implied information and statements that might be deemed forward-looking information and statements in respect of OSE Immunotherapeutics. They do not constitute historical facts. These information and statements include financial projections that are based upon certain assumptions and assessments made by OSE Immunotherapeutics' management considering its experience and its perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. These forward-looking statements include statements typically using conditional and containing verbs such as 'expect', 'anticipate', 'believe', 'target', 'plan', or 'estimate', their declensions and conjugations and words of similar import. Although the OSE Immunotherapeutics management believes that the forward-looking statements and information are reasonable, the OSE Immunotherapeutics' shareholders and other investors are cautioned that the completion of such expectations is by nature subject to various risks, known or not, and uncertainties which are difficult to predict and generally beyond the control of OSE Immunotherapeutics. These risks could cause actual results and developments to differ materially from those expressed in or implied or projected by the forward-looking statements. These risks include those discussed or identified in the public filings made by OSE Immunotherapeutics with the AMF. Such forward-looking statements are not guarantees of future performance. This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on April 30, 2025, including the annual financial report for the fiscal year 2024, available on the OSE Immunotherapeutics' website. Other than as required by applicable law, OSE Immunotherapeutics issues this press release at the date hereof and does not undertake any obligation to update or revise the forward-looking information or statements. Attachments FR_250716_Contrat liquidité EN_250716_Liquidity contractError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
09-07-2025
- Business
- Yahoo
Invitation to Stora Enso's Q2 2025 results webcast on 23 July 2025
STORA ENSO OYJ INVESTOR NEWS 9 July 2025 at 9:00 EEST HELSINKI, July 9, 2025 /PRNewswire/ -- Stora Enso will publish its Q2 results and Half-year Report for January–June 2025 on Wednesday 23 July at approximately 8:30 EEST (7:30 CEST). Analysts, investors, and media are invited to participate in the webcast with a teleconference at 11:00 am EEST (10:00 CEST, 9:00 BST, 4:00 EDT) on the same day. The results will be presented by President and CEO Hans Sohlström and CFO Niclas Rosenlew. The presentation can be followed live via the link: The webcast link will also be available on Stora Enso's website: During the webcast presentation, analysts and investors will also have the possibility to ask questions. To participate in the teleconference, please choose the 'Teleconference' option on the homepage of the webcast. A recording of the presentation will be available at and on Media representatives who wish to ask questions after the publication of the Interim Report may contact Carl Norell, SVP Corporate Communications at Stora Enso on +46 72 241 0349. Stora Enso The forest is at the heart of Stora Enso, and we believe that everything made from fossil-based materials today can be made from a tree tomorrow. We are the leading provider of renewable products in packaging, biomaterials, and wooden construction, and one of the largest private forest owners in the world. Stora Enso has approximately 19,000 employees and our sales in 2024 were EUR 9 billion. Stora Enso shares are listed on Nasdaq Helsinki Oy (STEAV, STERV) and Nasdaq Stockholm AB (STE A, STE R). In addition, the shares are traded in the USA on OTC Markets (OTCQX) as ADRs and ordinary shares (SEOAY, SEOFF, SEOJF). STORA ENSO OYJ Media enquiries:Carl NorellSVP Corporate Communicationstel. +46 72 241 0349Investor enquiries:Jutta MikkolaSVP Investor Relationstel. +358 50 544 6061 This information was brought to you by Cision View original content:
Yahoo
07-07-2025
- Business
- Yahoo
Vaisala's Half Year Financial Report January–June 2025 to be published on July 25, 2025
Vaisala CorporationPress releaseJuly 7, 2025, at 1:00 p.m. (EEST) Vaisala's Half Year Financial Report January–June 2025 to be published on July 25, 2025 Vaisala Corporation will publish its Half Year Financial Report January–June 2025 on Friday, July 25, 2025, at about 9:00 a.m. (Finnish time). The report will be available at The President and CEO's presentation will be published by 1:00 p.m. on the same day at Audiocast and teleconference An audiocast and a conference call for analysts, investors, and media will be held in English on the same day, starting at 1:00 p.m. (Finnish time). You can participate in the live audiocast via the following link: Questions may be presented by participating in the teleconference. You can access the teleconference by registering at the link below. After registration, you will receive an email with the dial-in numbers and a conference ID. A recording will be available at later the same informationNiina Ala-Luopa+358 400 728 957, ir@ DistributionKey is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data to improve resource efficiency, drive energy transition, and care for the safety and well-being of people and societies worldwide. With almost 90 years of innovation and expertise, we employ a team of close to 2,500 experts committed to taking every measure for the planet. Vaisala series A shares are listed on the Nasdaq Helsinki stock exchange.
Yahoo
04-07-2025
- Business
- Yahoo
Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025
ORION CORPORATION PRESS RELEASE 4 JULY 2025 at 09.00 EEST Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025 Orion will publish Half-Year Financial Report for January–June 2025 on Friday, 18 July 2025 at approximately 12.00 noon EEST. The report and related presentation material will be available on the company's website at after publishing. Webcast and conference call A webcast and a conference call for analysts, investors and media representatives will be held on Friday, 18 July 2025 at 13.30 EEST. A link to the live webcast is available on Orion's website at A recording of the event will be available on the website later the same day. Confenrence call can be joined by registering through the following link: Phone numbers and the conference ID to access the conference will be provided after the registration. In case you would like to ask a question during the conference, please dial *5 on your telephone keypad to enter the question queue. Questions can also be presented in writing through the question form of the webcast. Silent period The silent period preceding the publication is ongoing and continues until the disclosure. Contact person:Tuukka Hirvonen, Head of Investor Relations tel. +358 10 426 2721 Publisher:Orion CorporationCommunicationsOrionintie 1A, FI-02200 Espoo, Orion is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. In 2024 Orion's net sales amounted to EUR 1,542 million and the company employed about 3,700 professionals worldwide, dedicated to building well-being. Orion's A and B shares are listed on Nasdaq while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
02-07-2025
- Business
- Yahoo
Verkkokauppa.com to publish January-June 2025 Half-year Report on 17 July 2025
Oyj INVESTOR NEWS 2 July 2025 at 14:00 a.m. EEST to publish January-June 2025 Half-year Report on 17 July 2025 Oyj will publish the January-June 2025 Half-year Report on Thursday 17 July 2025, at approximately 8:00 a.m. Finnish time. CEO Panu Porkka will present the results in Finnish in a live webcast for analysts, investors, and media on the same day at 10:00 a.m. Finnish time. In addition, CEO Panu Porkka will present the results in English in a live webcast on the result publication day at 11:00 a.m. Finnish time. Both events can be viewed as a live stream at or at Questions can be presented either beforehand or during the presentation via e-mail at investors@ The presentation material will be available at after publishing the report. After the events, an on-demand presentation recording is available on the company's investors website. For further information investors@ Lauri Kutila, Head of Brand and Communications is an e-commerce pioneer that stands passionately on the customer's side. accelerates the transition of commerce to online with Finland's fastest deliveries and ultimate convenience. The company leads the way by offering one-hour deliveries to more than 1.7 million customers, a winning assortment and probably always cheaper prices. Every day, the company strives to find more streamlined ways to surpass its customers´ expectations and to create a new norm for buying and owning. was founded in 1992 and has been online since day one. The company's revenue in 2024 was EUR 468 million and it employs around 600 people. is listed on the Nasdaq Helsinki stock exchange. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
